English | 繁體

Search in the results

UM

Browse/Search Results:  1-1 of 1 Help

Selected(0)Clear Items/Page:    Sort:
Artesunate, a new antimalarial clinical drug, exhibits potent anti-AML activity by targeting the ROS/Bim and TFRC/Fe2+ pathways Journal article
Liu, Yi, Li, Han, Luo, Zhihong, Yu, You, Yang, Jingzhao, Zhang, Min, Law, Betty Yuen Kwan, Huang, Zan, Li, Wenhua. Artesunate, a new antimalarial clinical drug, exhibits potent anti-AML activity by targeting the ROS/Bim and TFRC/Fe2+ pathways[J]. British Journal of Pharmacology, 2022, 180(6), 701-720.
Authors:  Liu, Yi;  Li, Han;  Luo, Zhihong;  Yu, You;  Yang, Jingzhao; et al.
Favorite | TC[WOS]:4 TC[Scopus]:4  IF:6.8/7.4 | Submit date：2023/01/30
Acute Myeloid Leukaemia  Apoptosis  Artesunate  Bim  Differentiation  Tfrc